{"id":61360,"date":"2025-06-03T01:03:48","date_gmt":"2025-06-02T23:03:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/"},"modified":"2025-06-03T01:03:48","modified_gmt":"2025-06-02T23:03:48","slug":"rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/","title":{"rendered":"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company"},"content":{"rendered":"
\n

TOKYO–(BUSINESS WIRE)–Reinsurance Group of America, Incorporated<\/a> (NYSE: RGA), a leading global life and health reinsurer, today announced that it reached an agreement with The Dai-ichi Life Insurance Company, Limited (Dai-ichi) for an RGA subsidiary to reinsure 150 billion JPY of statutory reserves through coinsurance.<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cBuilding on our successful collaboration with Dai-ichi since 2020, we are thrilled to announce this latest transaction in our continued partnership,\u201d said Gaston Nossiter, Senior Vice President, Japan; Asia Pacific Financial Solutions, RGA. \u201cThis agreement reinforces RGA\u2019s commitment to providing leading reinsurance solutions in the Asian insurance market, empowering insurers with creative and tailored offerings that optimize capital and enhance risk management capabilities.\u201d<\/p>\n

\nRGA, a worldwide leader in reinsurance, pioneered asset-intensive solutions as financial optimization tools. Since executing its first such transaction in Asia in 1996, RGA has successfully implemented numerous coinsurance deals across the Asia Pacific region, delivering lasting value to clients and consumers across diverse markets.<\/p>\n

\nThe effective date of the transaction is March 31, 2025.<\/p>\n

\nAbout RGA<\/b><\/p>\n

\nReinsurance Group of America, Incorporated<\/a> (NYSE: RGA) is a global industry leader specializing in life and health reinsurance and financial solutions that help clients effectively manage risk and optimize capital. Founded in 1973, RGA is today one of the world\u2019s largest and most respected reinsurers and remains guided by a powerful purpose: to make financial protection accessible to all. As a global capabilities and solutions leader, RGA empowers partners through bold innovation, relentless execution, and dedicated client focus \u2014 all directed toward creating sustainable long-term value. RGA has approximately $3.9 trillion of life reinsurance in force and assets of $118.7 billion as of December 31, 2024. To learn more about RGA and its businesses, please visit rgare.com<\/a> or follow RGA on LinkedIn<\/a> and Facebook<\/a>. Investors can learn more at investor.rgare.com<\/a>.<\/p>\n

Contacts<\/b> <\/p>\n

\nFOR MORE INFORMATION:<\/p>\n

\nJeff Hopson
\n
Senior Vice President, Investor Relations
\n
636-736-2068
\n
jhopson@rgare.com<\/a><\/p>\n

\nLynn Phillips
\n
Vice President, Corporate Communications
\n
636-736-2351
\n
lphillips@rgare.com<\/a><\/p>\n

\nLizzie Curry
\n
Executive Director, Public Relations
\n
636-736-8521
\n
lizzie.curry@rgare.com<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

TOKYO–(BUSINESS WIRE)–Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, today announced that it reached an agreement with The Dai-ichi Life Insurance Company, Limited (Dai-ichi) for an RGA subsidiary to reinsure 150 billion JPY of statutory reserves through coinsurance. \u201cBuilding on our successful collaboration with Dai-ichi since 2020, we are … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-61360","6":"format-standard","7":"category-industry"},"yoast_head":"\nRGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"TOKYO–(BUSINESS WIRE)–Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, today announced that it reached an agreement with The Dai-ichi Life Insurance Company, Limited (Dai-ichi) for an RGA subsidiary to reinsure 150 billion JPY of statutory reserves through coinsurance. \u201cBuilding on our successful collaboration with Dai-ichi since 2020, we are ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-02T23:03:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20250602567455\/en\/2014893\/22\/RGA_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company\",\"datePublished\":\"2025-06-02T23:03:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/\"},\"wordCount\":341,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250602567455\\\/en\\\/2014893\\\/22\\\/RGA_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/\",\"name\":\"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250602567455\\\/en\\\/2014893\\\/22\\\/RGA_logo.jpg\",\"datePublished\":\"2025-06-02T23:03:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250602567455\\\/en\\\/2014893\\\/22\\\/RGA_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20250602567455\\\/en\\\/2014893\\\/22\\\/RGA_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/","og_locale":"en_US","og_type":"article","og_title":"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company - Pharma Trend","og_description":"TOKYO–(BUSINESS WIRE)–Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global life and health reinsurer, today announced that it reached an agreement with The Dai-ichi Life Insurance Company, Limited (Dai-ichi) for an RGA subsidiary to reinsure 150 billion JPY of statutory reserves through coinsurance. \u201cBuilding on our successful collaboration with Dai-ichi since 2020, we are ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/","og_site_name":"Pharma Trend","article_published_time":"2025-06-02T23:03:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20250602567455\/en\/2014893\/22\/RGA_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company","datePublished":"2025-06-02T23:03:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/"},"wordCount":341,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250602567455\/en\/2014893\/22\/RGA_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/","url":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/","name":"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20250602567455\/en\/2014893\/22\/RGA_logo.jpg","datePublished":"2025-06-02T23:03:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20250602567455\/en\/2014893\/22\/RGA_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20250602567455\/en\/2014893\/22\/RGA_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/rga-announces-150-billion-jpy-coinsurance-transaction-with-the-dai-ichi-life-insurance-company\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"RGA Announces 150 Billion JPY Coinsurance Transaction with The Dai-ichi Life Insurance Company"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61360","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=61360"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/61360\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=61360"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=61360"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=61360"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}